Home > Healthcare > Pharmaceuticals > Finished Drug Form > Antibiotic Resistance Market

Antibiotic Resistance Market Share

Report ID: GMI6499
Published Date: Aug 2023
Report Format: PDF

Download Free Sample

Antibiotic Resistance Market Share

The key players in the antibiotic resistance market are :

ACHAOGEN, INC.
Basilea Pharmaceutica Ltd.
MELINTA THERAPEUTICS
Tetraphase Pharmaceuticals, Inc.
Theravance Biopharma
WOCKHARDT
Entasis therapeutics
Paratek Pharmaceuticals
Inc., Seres Therapeutics
AbbVie, Inc.,
Merck & Co. Inc.
and Pfizer, Inc.

These companies are implementing several strategies such as collaborations, acquisitions, partnerships, mergers, and product launches to maintain a competitive edge in the industry.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Antibiotic resistance industry size was USD 8.2 billion in 2022 and will reach USD 13.6 billion by the end of 2032 due to the rising investments in research and development along with the increasing global public health concern and awareness.

The hospital pharmacies distribution channel segment held 54% share of the antibiotic resistance industry in 2022 due to the surging need for ensuring that antibiotics are prescribed properly as per the clinical need, susceptibility data, and guidelines.

North America antibiotic resistance market size may record USD 5.5 billion by 2032 driven by the surging government support and fundings in the region

Some of the prominent antibiotic resistance firms are MELINTA THERAPEUTICS, Tetraphase Pharmaceuticals, Inc., Theravance Biopharma, WOCKHARDT, Entasis therapeutics, Paratek Pharmaceuticals, Inc., Seres Therapeutics, AbbVie, Inc., Merck & Co. Inc., and Pfizer, Inc